# Dantrium

NDC: 42023-124
Generic name: dantrolene sodium
Labeler / Manufacturer: Endo USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20080801

FDA application: NDA017443

## Active ingredients

- DANTROLENE SODIUM: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42023-124"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42023-124
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=57b4eec1-49e1-432c-95ae-0fe36e32d64b